METTL14-mediated depression of NEIL1 aggravates oxidative damage and mitochondrial dysfunction of lens epithelial

Lihua Kang1, Sijie Bao1, Pengfei Li1

  • 1Eye Institute, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.

Cellular Signalling
|January 24, 2025
PubMed

Insights

The Nei Endonuclease VIII-Like1 (NEIL1) gene

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Age-related cataract (ARC) pathogenesis involves abnormal base excision repair (BER) and RNA N6-methyladenosine (m6A) modification.
  • The specific role of the NEIL1 gene, a key BER component, and its m6A modification in ARC remains largely unknown.

Purpose of the Study:

  • To investigate the function of NEIL1 and its m6A modification in the pathogenesis of age-related cataract.
  • To elucidate the underlying molecular mechanisms involving oxidative stress and mitochondrial homeostasis.

Main Methods:

  • Quantitative analysis of NEIL1 expression in ARC tissues and cells.
  • Investigating the effect of NEIL1 modulation on oxidative damage, apoptosis, and mitochondrial function.
  • Utilizing in vitro and in vivo models (rat lenses, Emory mice) to assess NEIL1's therapeutic potential.
  • Identifying m6A modification regulators (METTL14, YTHDF2) and their impact on NEIL1 RNA stability.

Main Results:

  • NEIL1 expression was decreased in ARC anterior lens capsules and H2O2-treated cells.
  • Ectopic NEIL1 expression reduced oxidative damage, apoptosis, and mitochondrial dysfunction by modulating the KEAP1/NRF2 pathway.
  • NEIL1 silencing exacerbated H2O2-induced lens opacity, while ML334 and AAV2-NEIL1 treatments mitigated opacity in vivo and ex vivo.
  • METTL14 promotes m6A modification of NEIL1, leading to YTHDF2-mediated degradation and reduced RNA stability.

Conclusions:

  • m6A modification of NEIL1 plays a critical role in regulating oxidative stress and mitochondrial homeostasis via the KEAP1/NRF2 pathway in ARC.
  • NEIL1 and its m6A modification represent a potential therapeutic target for age-related cataract.